Literature DB >> 7370086

Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome.

M L Kashyap, L S Srivastava, B A Hynd, D Brady, G Perisutti, C J Glueck, P S Gartside.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7370086     DOI： 10.1016/0021-9150(80)90025-8

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  8 in total

Review 1.  Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.

Authors:  Shipra Agrawal; Joshua J Zaritsky; Alessia Fornoni; William E Smoyer
Journal:  Nat Rev Nephrol       Date:  2017-11-27       Impact factor: 28.314

2.  Increased HDL Size and Enhanced Apo A-I Catabolic Rates Are Associated With Doxorubicin-Induced Proteinuria in New Zealand White Rabbits.

Authors:  Victoria López-Olmos; Elizabeth Carreón-Torres; María Luna-Luna; Cristobal Flores-Castillo; Miriam Martínez-Ramírez; Rocío Bautista-Pérez; Martha Franco; Julio Sandoval-Zárate; Francisco-Javier Roldán; Alberto Aranda-Fraustro; Elizabeth Soria-Castro; Mónica Muñoz-Vega; José-Manuel Fragoso; Gilberto Vargas-Alarcón; Oscar Pérez-Méndez
Journal:  Lipids       Date:  2016-01-19       Impact factor: 1.880

3.  Influence of glucose on production and N-sulfation of heparan sulfate in cultured adipocyte cells.

Authors:  N Parthasarathy; L F Gotow; J D Bottoms; J C Obunike; A Naggi; B Casu; I J Goldberg; W D Wagner
Journal:  Mol Cell Biochem       Date:  2000-10       Impact factor: 3.396

4.  Lipoproteins, HDL-apolipoproteins, activities of hepatic lipase and lecithin-cholesterol acyltransferase in the plasma of patients with post-alcoholic end-stage liver cirrhosis.

Authors:  C Breier; H J Lisch; H Braunsteiner
Journal:  Klin Wochenschr       Date:  1983-09-15

Review 5.  Lipid changes in the nephrotic syndrome: new insights into pathomechanisms and treatment.

Authors:  G D'Amico
Journal:  Klin Wochenschr       Date:  1991-09-03

6.  Magnesium pyridoxal 5-phosphate glutamate reduces hyperlipidaemia in patients with chronic renal insufficiency.

Authors:  R Kirsten; B Heintz; K Nelson; H G Sieberth; G Oremek; J Hasford; U Speck
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

7.  Preventive effect of Ibrolipim on suppressing lipid accumulation and increasing lipoprotein lipase in the kidneys of diet-induced diabetic minipigs.

Authors:  Yi Liu; Zong Bao Wang; Wei Dong Yin; Qin Kai Li; Man Bo Cai; Jian Yu; Hong Guang Li; Chi Zhang; Xiu Hong Zu
Journal:  Lipids Health Dis       Date:  2011-07-16       Impact factor: 3.876

8.  The lipid story in chronic kidney disease: a long story with a happy end?

Authors:  Agata Kujawa-Szewieczek; Andrzej Więcek; Grzegorz Piecha
Journal:  Int Urol Nephrol       Date:  2013-10       Impact factor: 2.370
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.